Advances, setbacks seen in breast cancer research

The fight against breast cancer, the second most dangerous after lung cancer, is making progress, but has experienced a number of setbacks, scientists said.

The most interesting progress was reported in a new study unveiled here Sunday that found that a new agent derived from a marine sponge can extend the survival rates of women with locally recurrent or metastatic breast cancer who already received extensive standard therapy.

The synthetic component called eribulin mesylate mimics a component found naturally in sponges and can prevent cell division, which causes cells to self-destruct, said study authors who presented their findings at the annual American Society of Clinical Oncology conference here.

In a randomized international trial, British researchers assessed the survival rates of 762 patients, treated either with eribulin or another therapy, almost always chemotherapy, and found the new therapy extended median overall survival by about 2.5 months.

"Until now, there hasn't been a standard treatment for women with such advanced breast cancer. For those who have already received all of the recognized treatments, these are promising results," said lead study author Christopher Twelves.

"These findings may establish eribulin as a new, effective option for women with heavily pre-treated metastatic breast cancer," said Twelves, head of the Clinical Cancer Research Groups at the Leeds Institute of Molecular Medicine in Britain.

The most frequently reported adverse effects among patients treated with eribulin were fatigue (53.7 percent), low white blood cell counts (51.7 percent), hair loss (44.5 percent) and numbness and tingling in different parts of the body (34.6 percent).

Serious adverse effects were reported for 25 percent of patients, the researchers said.

More than one million women a year are diagnosed with breast cancer worldwide, according to international statistics.

Approximately 50 percent of them are expected to develop recurrent or metastatic disease within 15 years of their first diagnosis.

Only one in five women with metastatic breast cancer survives longer than five years.

In the United States, an estimated 155,000 women are currently living with metastatic breast cancer, and that number is projected to increase to 162,000 by 2011.

"Women with advanced breast cancer are in critical need of new treatment options," said Alton Kremer, head of clinical development for oncology at Eisai Inc., the developer of eribulin

"In this study, eribulin has shown an improvement in survival, and if approved by health authorities, it may offer patients a new treatment option at this stage of the disease," he added

An application for marketing the drug was granted priority review status by the US Food and Drug Administration last month.

Another study presented at the conference showed that partial targeted irradiation of affected breasts can be effective. But some researchers reported setbacks.

A study by the John Wayne Cancer Institute in Santa Monica, Calififornia has concluded that removing additional underarm lymph nodes to look for more breast cancer cells in women with limited disease spread does not improve survival.

An observational trial of more than 5,500 women with early-stage breast cancer who had breastsparing surgery showed that using immunohistochemistry to detect hidden micrometastases in sentinel lymph nodes and bone marrow does not predict overall survival and should not be used to guide treatment decisions.

Yet another report found that shows that the characteristics of tumors in women with metastatic breast cancer often change when cancer spreads to the liver, requiring a change in therapy in more than 12 percent of patients.

News
people And here is why...
News
people
News
peopleStella McCartney apologises over controversial Instagram picture
Arts and Entertainment
Hayley Williams performs with Paramore in New York
musicParamore singer says 'Steal Your Girl' is itself stolen from a New Found Glory hit
PROMOTED VIDEO
Life and Style
ebooksA superb mix of recipes serving up the freshest of local produce in a delicious range of styles
Life and Style
ebooksFrom the lifespan of a slug to the distance to the Sun: answers to 500 questions from readers
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Associate Recrutiment Consultant

    £18000 - £23000 per annum + Uncapped OTE: SThree: SThree Group have been well ...

    Trainee Recruitment Consultant

    £18000 - £23000 per annum + OTE: SThree: Real Staffing Group is seeking Traine...

    Year 6 Teacher (interventions)

    £120 - £140 per day: Randstad Education Leeds: We have an exciting opportunity...

    PMLD Teacher

    Competitive: Randstad Education Manchester: SEN Teacher urgently required for ...

    Day In a Page

    Ebola outbreak: The children orphaned by the virus – then rejected by surviving relatives over fear of infection

    The children orphaned by Ebola...

    ... then rejected by surviving relatives over fear of infection
    Pride: Are censors pandering to homophobia?

    Are censors pandering to homophobia?

    US film censors have ruled 'Pride' unfit for under-16s, though it contains no sex or violence
    The magic of roundabouts

    Lords of the rings

    Just who are the Roundabout Appreciation Society?
    Why do we like making lists?

    Notes to self: Why do we like making lists?

    Well it was good enough for Ancient Egyptians and Picasso...
    Hong Kong protests: A good time to open a new restaurant?

    A good time to open a new restaurant in Hong Kong?

    As pro-democracy demonstrators hold firm, chef Rowley Leigh, who's in the city to open a new restaurant, says you couldn't hope to meet a nicer bunch
    Paris Fashion Week: Karl Lagerfeld leads a feminist riot on 'Boulevard Chanel'

    Paris Fashion Week

    Lagerfeld leads a feminist riot on 'Boulevard Chanel'
    Bruce Chatwin's Wales: One of the finest one-day walks in Britain

    Simon Calder discovers Bruce Chatwin's Wales

    One of the finest one-day walks you could hope for - in Britain
    10 best children's nightwear

    10 best children's nightwear

    Make sure the kids stay cosy on cooler autumn nights in this selection of pjs, onesies and nighties
    Manchester City vs Roma: Five things we learnt from City’s draw at the Etihad

    Manchester City vs Roma

    Five things we learnt from City’s Champions League draw at the Etihad
    Martin Hardy: Mike Ashley must act now and end the Alan Pardew reign

    Trouble on the Tyne

    Ashley must act now and end Pardew's reign at Newcastle, says Martin Hardy
    Isis is an hour from Baghdad, the Iraq army has little chance against it, and air strikes won't help

    Isis an hour away from Baghdad -

    and with no sign of Iraq army being able to make a successful counter-attack
    Turner Prize 2014 is frustratingly timid

    Turner Prize 2014 is frustratingly timid

    The exhibition nods to rich and potentially brilliant ideas, but steps back
    Last chance to see: Half the world’s animals have disappeared over the last 40 years

    Last chance to see...

    The Earth’s animal wildlife population has halved in 40 years
    So here's why teenagers are always grumpy - and it's not what you think

    Truth behind teens' grumpiness

    Early school hours mess with their biological clocks
    Why can no one stop hackers putting celebrities' private photos online?

    Hacked photos: the third wave

    Why can no one stop hackers putting celebrities' private photos online?